Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) dose that’s inconsistent with US Food and Drug Administration labeling—a practice believed, in many cases, to be ...
Use of half-dose direct oral anticoagulants (DOACs) showed promise as a long-term prophylactic strategy after successful percutaneous left atrial appendage (LAA) occlusion, according to an ...
Use of a different dose of a direct oral anticoagulant (DOAC) than the one recommended on the package insert—usually a lower one—is common around the world and is associated with poorer outcomes, data ...
The prevalence of inappropriate direct oral anticoagulant (DOAC) dosing in patients with atrial fibrillation (AF) was 25%. Several demographic factors such as advanced age, presence of chronic kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback